Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Energy Industry News Baker Hughes cleared its biggest regulatory hurdle, but the Chart deal comes with strings Baker Hughes won EU clearance for its $13.6 billion Chart deal, but divestitures, ten-year LNG safeguards and new debt still define the execution test. byVenkateshJuly 13, 2026